carmustine has been researched along with misonidazole in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (78.57) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levin, VA | 1 |
| Scavone, SV; Sebolt-Leopold, JS | 1 |
| Urano, M; Wong, KH | 1 |
| Wallen, CA; Wheeler, KT; Wong, KH; Zhang, H | 1 |
| Wallen, CA; Wheeler, KT; Wong, KH | 3 |
| Burger, PC; Deutsch, M; Green, SB; Mealey, J; Paoletti, P; Ransohoff, J; Robertson, JT; Selker, RG; Shapiro, WR; Strike, TA | 1 |
| Gutin, PH; Nelson, DF; Saunders, WM; Sheline, GE; Urtasun, RC | 1 |
| Diener-West, M; Nelson, DF; Pakuris, E; Weinstein, AS | 1 |
| Carabell, S; Chang, CH; Diener-West, M; Goodman, R; Nelson, DF; Nelson, JS; Sause, WT; Schoenfeld, D; Weinstein, AS | 1 |
| Mulcahy, RT; Siemann, DW | 2 |
| Mulcahy, RT; Siemann, DW; Sutherland, RM | 2 |
| Adams, GE | 1 |
| Lee, FY; Workman, P | 1 |
| Carabell, S; Goodman, RL; Nelson, DF; Nelson, JS; Schoenfeld, D; Wasserman, T; Weinstein, AS | 1 |
| Siemann, DW; Wallen, CA; Wheeler, KT; Wolf, KL | 1 |
| Morrissey, S; Siemann, DW; Wheeler, KT; Wolf, K | 1 |
| Dembs, N; Mulcahy, RT | 1 |
| Csejtey, J; Landahl, HD; Levin, VA; Patlak, CS; Wright, DC | 1 |
| Siemann, DW | 1 |
| Clutterbuck, RD; McElwain, TJ; Millar, JL | 1 |
| Allen, N | 1 |
| Twentyman, PR | 1 |
| Tannock, IF | 1 |
| Abbott, NJ; Chan, MW; Ray, DE; Romero, IA | 1 |
2 review(s) available for carmustine and misonidazole
| Article | Year |
|---|---|
Recent and current investigations of radiation therapy of malignant gliomas.
Topics: Brachytherapy; Brain; Brain Neoplasms; Bromodeoxyuridine; Carmustine; Glioma; Helium; Humans; Hyperbaric Oxygenation; Hyperthermia, Induced; Mesons; Metronidazole; Middle Aged; Misonidazole; Neon; Neutrons; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy, High-Energy | 1986 |
Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review.
Topics: Anaerobiosis; Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Synergism; Lomustine; Mice; Misonidazole; Neoplasms, Experimental; Radiation-Sensitizing Agents | 1982 |
4 trial(s) available for carmustine and misonidazole
| Article | Year |
|---|---|
Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
Topics: Adolescent; Adult; Aged; Astrocytoma; Carmustine; Combined Modality Therapy; Glioblastoma; Glioma; Humans; Middle Aged; Misonidazole; Multicenter Studies as Topic; Prognosis; Radiotherapy Dosage; Random Allocation; Streptozocin; Supratentorial Neoplasms | 1989 |
Pulmonary toxicity of carmustine in patients treated for malignant glioma.
Topics: Adult; Aged; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Glioma; Humans; Lung Diseases; Male; Middle Aged; Misonidazole; Random Allocation; Risk | 1986 |
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
Topics: Adult; Aged; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Middle Aged; Misonidazole; Prognosis; Radiation-Sensitizing Agents; Random Allocation | 1986 |
A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Drug Administration Schedule; Glioma; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prospective Studies; Radiation-Sensitizing Agents; Random Allocation | 1983 |
22 other study(ies) available for carmustine and misonidazole
| Article | Year |
|---|---|
Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability.
Topics: Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Male; Models, Biological; Molecular Weight; Rats; Rats, Inbred F344; Solubility; Structure-Activity Relationship | 1980 |
Enhancement of alkylating agent activity in vitro by PD 128763, a potent poly(ADP-ribose) synthetase inhibitor.
Topics: Alkylating Agents; Animals; Carmustine; Drug Synergism; In Vitro Techniques; Isoquinolines; Leukemia L1210; Misonidazole; Poly(ADP-ribose) Polymerase Inhibitors; Streptozocin; Tumor Cells, Cultured | 1992 |
Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
Topics: Animals; Carmustine; Cyclophosphamide; Hyperthermia, Induced; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental | 1992 |
Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
Topics: Animals; Carmustine; Drug Synergism; Male; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Rats; Rats, Inbred F344; Survival Rate | 1992 |
2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cell Line; Cell Survival; Drug Synergism; Etanidazole; Lomustine; Male; Misonidazole; Nitroimidazoles; Rats; Rats, Inbred F344; Streptozocin; Tumor Stem Cell Assay | 1991 |
Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Topics: Animals; Carmustine; Drug Synergism; Etanidazole; Lomustine; Male; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Nitrosourea Compounds; Rats; Rats, Inbred F344; Structure-Activity Relationship | 1990 |
Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
Topics: Animals; Biological Availability; Carmustine; Constriction; Drug Interactions; Half-Life; Male; Misonidazole; Neoplasms, Experimental; Rats; Rats, Inbred F344; Regional Blood Flow; Tissue Distribution | 1989 |
Sensitization of cancer chemotherapeutic agents by nitroheterocyclics.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Survival; Drug Synergism; Heterocyclic Compounds; Hydroxamic Acids; Hypoxia; Lomustine; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Cells, Cultured; Colony-Forming Units Assay; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Streptozocin | 1982 |
Radiosensitizers: a conference preview.
Topics: Animals; Aziridines; Buthionine Sulfoximine; Carmustine; Combined Modality Therapy; Drug Synergism; Etanidazole; Humans; Ketones; Lomustine; Maleates; Methionine Sulfoximine; Mice; Misonidazole; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.
Topics: Animals; Antineoplastic Agents; Carmustine; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Radiation-Sensitizing Agents; Semustine; Streptozocin; Time Factors | 1984 |
Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Lomustine; Misonidazole; Nitroimidazoles; Oxygen; Rats; Skin Neoplasms; Tumor Stem Cell Assay | 1984 |
In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Survival; Cells, Cultured; Drug Synergism; Misonidazole; Nitroimidazoles; Rats | 1984 |
Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
Topics: Animals; Carmustine; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Fibrosarcoma; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1983 |
In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Topics: Animals; Carmustine; Cell Line; Drug Resistance; Drug Synergism; Humans; Leukemia L1210; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Nitrosourea Compounds; Sarcoma, Experimental | 1983 |
In situ drug delivery.
Topics: Animals; Capillaries; Carmustine; Half-Life; Misonidazole; Models, Biological; Neoplasms, Experimental; Nitroimidazoles; Rats | 1980 |
Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carmustine; Cell Line; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Melanoma; Melphalan; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Transplantation, Heterologous | 1982 |
Experimental therapy of brain tumors.
Topics: Animals; Brain Neoplasms; Carmustine; Cell Line; Methods; Metronidazole; Misonidazole; Neoplasms, Experimental; Radiation-Sensitizing Agents; Rats; Sulfhydryl Compounds; Vitamin A | 1980 |
The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; In Vitro Techniques; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Topics: Animals; Body Weight; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Fibrosarcoma; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
Topics: Animals; Carmustine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental; Time Factors | 1981 |
Increased oxidative metabolism and oxidative stress in m-dinitrobenzene neurotoxicity.
Topics: Animals; Animals, Newborn; Astrocytes; Brain; Carmustine; Cell Survival; Cells, Cultured; Deferoxamine; Dinitrobenzenes; Glutathione; Glutathione Disulfide; Glycolysis; L-Lactate Dehydrogenase; Lactates; Male; Misonidazole; Neurotoxins; Nitrofurazone; Oxidative Stress; Rats; Rats, Inbred F344 | 1994 |